2,695 followers
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity. https://t.co/X3je0JffKu. Retrospective data of 5 patients. Dose used was 100 mg in most.
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity. https://t.co/X3je0JffKu. Retrospective data of 5 patients. Dose used was 100 mg in most.
RT @graham74GC: Interesting small study - low dose pembro maybe very active in Hodgkin. Would be a lot cheaper too! #lymsm https://t.co/tp4…
efficacy with 100mg sounds amazing https://t.co/MkPZaWfKWf
Interesting small study - low dose pembro maybe very active in Hodgkin. Would be a lot cheaper too! #lymsm https://t.co/tp4tWraJth